Related Experiment Video
Updated: May 17, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Cytisin amidophosphate--the new cytoprotector
Zhaxybay Zhumadilov1, Talgat Nurgozhin, Alexandr Gulyaev
1Center for Life Sciences, Nazarbayev University, Kabanbay batyr ave. 53, Astana, Republic of Kazakhstan.
O,O dimethyl-N-cytinizylphosphate demonstrated good tolerability and high efficacy in treating acute toxic hepatitis. Patients experienced faster recovery and significant improvement after the first dose compared to standard treatments.
Area of Science:
- Pharmacology
- Hepatology
- Clinical Toxicology
Background:
- Acute toxic hepatitis poses a significant health challenge.
- Standard treatments for acute toxic hepatitis have limitations.
- Novel therapeutic agents are needed for effective management.
Purpose of the Study:
- To evaluate the safety and efficacy of O,O dimethyl-N-cytinizylphosphate.
- To compare the drug's performance against standard treatments for acute toxic hepatitis.
Main Methods:
- Clinical study involving healthy volunteers.
- Study included 142 patients diagnosed with acute toxic hepatitis.
- Assessed tolerability, time to normalization, and speed of improvement.
Main Results:
- O,O dimethyl-N-cytinizylphosphate showed good tolerability.
- The drug exhibited very high efficiency in treating acute toxic hepatitis.
- Significant improvement observed immediately after the first injection.
- Normalization of patient condition occurred in less time compared to standard treatment.
Conclusions:
- O,O dimethyl-N-cytinizylphosphate is a well-tolerated and highly effective treatment for acute toxic hepatitis.
- The drug offers a faster and more effective therapeutic option compared to existing standards.
- Early administration leads to rapid and significant patient recovery.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:12Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Related Concept Videos
Anthelminthic Agents
Antifungal Agents
Anaphase Promoting Complex
Drugs that Destabilize Microtubules
Inhibitors of Bacterial Protein Synthesis
Drugs that Stabilize Microtubules